Insider Tip: Some reputable clinics offer a combination peptide therapy containing TB4/TB-500 and BPC-157, or body protection compound 157
Step One Starting Well aims to (i) enhance mutual understanding of the cognitive-behavioral mechanisms that sustain a patients BED, (ii) reduce preoccupation with weight, (iii) decrease the frequency of binge-eating episodes, and (iv) promote the adoption of an active lifestyle
However, discontinuing GLP-1 therapy can be challenging, especially given the lack of clear guidelines on how to taper off these medications and the common trend of weight regain post-treatment
Share your Subscriber Article You have 5 articles to share every month
Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis
If youre taking a GLP-1 medication like semaglutide or tirzepatide, you may notice that your appetite starts whispering instead of shouting